Quick Answer
Virax Biolabs Group Ltd reported Gross Profit of -$53.1 thousand for fiscal year 2025.
Virax Biolabs Group Ltd Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | -$53.1K | -204.9% |
| 2024 | $50.6K | +3806.2% |
| 2023 | -$1.4K | +85.5% |
| 2021 | -$9.4K | — |
- Virax Biolabs Group Ltd showed a decrease of -204.9% in Gross Profit compared to the prior fiscal year.
- Over the 2021–2025 period, Virax Biolabs Group Ltd’s gross profit has declined by 462.5% (from -$9.4 thousand to -$53.1 thousand).
- The most recent figure is from Virax Biolabs Group Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 2, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: